Ifp Advisors, Inc Iovance Biotherapeutics, Inc. Transaction History

Ifp Advisors, Inc

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$7.17 - $12.28 $0 - $0	0 New	0 $0
Q2 2023 Aug 04, 2023	BUY	$5.36 - $9.06 $1,608 - $2,718	300 New	300 $2,000
Q4 2022 Feb 07, 2023	SELL	$5.62 - $10.0 $269 - $480	-48 Reduced 3.74%	1,235 $18,000
Q3 2022 Nov 08, 2022	BUY	$9.53 - $13.11 $10,483 - $14,421	1,100 Added 601.09%	1,283 $18,000
Q2 2022 Sep 06, 2022	BUY	$6.38 - $18.33 $1,167 - $3,354	183 New	183 $2,000
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $1,167 - $3,354	-183 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$12.38 - $19.1 $2,265 - $3,495	183 New	183 $3,000
Q4 2021 Jan 12, 2022	SELL	$16.55 - $27.63 $810 - $1,353	-49 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$20.35 - $26.63 $997 - $1,304	49 New	49 $1,000
Q2 2021 Jul 13, 2021	SELL	$16.33 - $33.07 $65 - $132	-4 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$28.67 - $52.59 $1,748 - $3,207	-61 Reduced 93.85%	4 $0
Q4 2020 Jan 25, 2021	BUY	$28.04 - $50.26 $1,402 - $2,513	50 Added 333.33%	65 $3,000
Q3 2020 Oct 29, 2020	BUY	$27.75 - $36.3 $416 - $544	15 New	15 $0
Q2 2020 Aug 05, 2020	BUY	$27.21 - $41.0 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$19.54 - $38.85 $0 - $0	0 New	0 $0

316

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.